Press Releases

08.04.2015

Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira

08.03.2015

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

07.28.2015

PFIZER REPORTS SECOND-QUARTER 2015 RESULTS

07.22.2015

Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility

07.08.2015

Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research

07.07.2015

Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery

07.02.2015

Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets

06.25.2015

Joseph J. Echevarria Elected To Pfizer’s Board Of Directors

06.25.2015

Pfizer Declares 28-Cent Third-Quarter 2015 Dividend

06.24.2015

CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age

06.23.2015

Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease

06.23.2015

Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts